Muto, Satoru
Matsubara, Takeshi http://orcid.org/0000-0002-2380-1551
Inoue, Takamitsu
Kitamura, Hiroshi
Yamamoto, Kazuhiro
Ishii, Taisuke
Yazawa, Masahiko
Yamamoto, Ryohei
Okada, Naoto
Mori, Kiyoshi
Yamada, Hiroyuki
Kuwabara, Takashige
Yonezawa, Atsushi
Fujimaru, Takuya
Kawano, Haruna
Yokoi, Hideki
Doi, Kent
Hoshino, Junichi
Yanagita, Motoko
Article History
Received: 22 May 2023
Accepted: 14 June 2023
First Online: 29 June 2023
Declarations
:
: H. Kitamura has received honoraria from Astellas Pharma Inc, Takeda Pharmaceutical Company Limited, Bayer AG, and Janssen Pharmaceutical K.K., and scholarship donations from Takeda Pharmaceutical Company Limited and Bayer AG. T.K received honoraria from AstraZeneca. H. Yokoi has received honoraria from AstraZeneca and Mitsubishi Tanabe Pharma, and a scholarship donation from Mitsubishi Tanabe Pharmaceutical Corporation. J.H has received honoraria from Kyowa Kirin Co., Ltd., Mitsubishi Tanabe Pharma, Ono Pharm, AstraZeneca and Astellas Pharma Inc, and a research grant from Otsuka Pharmaceutical Co., Ltd. M. Yanagita has received honoraria from Astellas Pharma Inc, AstraZeneca, Kyowa Kirin Co., Ltd., Chugai-Pharmaceutical Co., Ltd., Bayer AG, and Mitsubishi Tanabe Pharma, and research grants from Mitsubishi Tanabe Pharma, Boehringer Ingelheim International GmbH, and scholarship donations from Kyowa Kirin Co., Ltd., Chugai-Pharmaceutical Co., Ltd., and Mitsubishi Tanabe Pharma. The other authors declare no potential conflicts of interest.